Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 16.04.2024
ad pepper media International N.V.
Nuremberg, Amsterdam, 16 April 2024
Today, ad pepper media International N.V., one of the leading European performance marketing companies, released its results for the first quarter of 2024. The Group generated gross sales of EUR 20,772k (Q1 2023: EUR 19,593k) and revenue of EUR 5,176k (Q1 2023: EUR 5,099k), corresponding to an increase of 6 perc [ … ]
Tue, 16.04.2024
Edison Investment Research Limited
London, UK, 16 April 2024
Edison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors
Tetragon Financial Group (Tetragon) posted a 6.4% net asset value (NAV) per share total return in US dollar terms in FY23. Tetragon’s returns normally have a low correlation with broader markets, and therefore its FY23 [ … ]
Tue, 16.04.2024
Edison Investment Research Limited
London, UK, 16 April 2024
Edison issues review on Tetragon Financial Group (TFG): FY23 growth driven by idiosyncratic factors
Tetragon Financial Group (Tetragon) posted a 6.4% net asset value (NAV) per share total return in US dollar terms in FY23. Tetragon’s returns normally have a low correlation with broader markets, and therefore its FY23 [ … ]
Tue, 16.04.2024
CureVac
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
Agreement creates strong synergies between CureVac’s unique end-to-end mRNA capabilities and MD Anderson’s translational and clinical research expertise
Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematologic [ … ]
Tue, 16.04.2024
creditshelf Aktiengesellschaft
Public disclosure of an insider information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse, as amended (Market Abuse Regulation - MAR).
CREDITSHELF AKTIENGESELLSCHAFT: EXISTING OFFERS FROM INVESTORS FOR CONTINUATION OR TAKEOVER OF BUSINESS OPERATIONS
Frankfurt am Main, 16 April 2024 - As part of a structured [ … ]
Tue, 16.04.2024
creditshelf Aktiengesellschaft
Public disclosure of an insider information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse, as amended (Market Abuse Regulation - MAR).
CREDITSHELF AKTIENGESELLSCHAFT: EXISTING OFFERS FROM INVESTORS FOR CONTINUATION OR TAKEOVER OF BUSINESS OPERATIONS
Frankfurt am Main, 16 April 2024 - As part of a structured [ … ]
Tue, 16.04.2024
Hapag-Lloyd AG
Setting Sail for the Future: Hapag-Lloyd unveils its new Strategy 2030
Building on the successes of Strategy 2023, Hapag-Lloyd’s Strategy 2030 remains dedicated to quality and sustainability, laying a strong foundation for the future.
With five core building blocks, Strategy 2030 adapts to the rapidly evolving maritime industry, ensuring resili [ … ]
Tue, 16.04.2024
Linde plc
Linde Recognized on 2024 World’s Most Ethical Companies® List
Woking, UK, April 16, 2024 – Linde (Nasdaq: LIN) announced today that it has received the 2024 World’s Most Ethical Companies® recognition from Ethisphere, Linde’s fourth consecutive year of inclusion.
The annual list highlights organizations that have demonstrated a commitment to bus [ … ]
Tue, 16.04.2024
AGRANA Beteiligungs-Aktiengesellschaft
Subdued outlook for 2024|25 after solid EBIT in 2023|24
Dividend proposal of € 0.90 per share for the 2023|24 financial year
Based on provisional results, AGRANA generated operating profit (EBIT) of € 151.0 million in its 2023|24 financial year (1 March 2023 to 29 February 2024), which is in line with its guidance of a very significant improvemen [ … ]
Tue, 16.04.2024
BRAIN Biotech AG
BRAIN Biotech AG takes next step to optimize group structure
BRAIN Biotech Group will merge AnalytiCon Discovery GmbH into BRAIN Biotech AG in order to further optimize and simplify the Group structure.
Zwingenberg, Germany, 16 April 2024 – The Management Board of BRAIN Biotech AG, with the approval of the Supervisory Board, has resolved to merge [ … ]